Molecular diversity and polymerase gene genotypes of HIV-1 among treatment-naïve Cameroonian subjects with advanced disease

Journal of Clinical Virology

Volumn 48, Issue 3, 2010, Pages 173-179

  Soares, Esmeralda A ^a   Makamche, Marie Florence ^b   Siqueira, Juliana D ^a   Lumngwena, Evelyn ^b   Mbuagbaw, Josephine ^b   Kaptue, Lazare ^b   Asonganyi, Tazoacha ^b   Seuánez, Héctor N ^a,c   Soares, Marcelo A ^a,c   Alemnji, George ^b  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Cameroon; Drug resistance; HIV 1; Recombination; RNase H

Indexed keywords

RIBONUCLEASE H; RNA DIRECTED DNA POLYMERASE; VIRUS RNA;

ADULT; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; BLOOD SAMPLING; CAMEROON; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE SEVERITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA EXTRACTION; VIRUS MUTATION; VIRUS RESISTANCE; VIRUS STRAIN;

ADULT; AMINO ACID SUBSTITUTION; CAMEROON; CLUSTER ANALYSIS; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; POLYMORPHISM, GENETIC; RNA, VIRAL; SEQUENCE ANALYSIS, DNA;

EID: 77953121624     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2010.04.008     Document Type: Article

References (34)

1. World Health Organization. Towards universal access by 2010: How WHO is working with countries to scale-up HIV prevention, treatment, care and support (2006)
2. Kuate S., Mikolajczyk R.T., Forgwei G.W., Tih P.M., Welty T.K., and Kretzschmar M. Time trends and regional differences in the prevalence of HIV Infection among women attending antenatal clinics in 2 provinces in Cameroon. J Acquir Immune Defic Syndr 52 2 (2009) 258-264
3. Robertson D.L., Anderson J.P., Bradac J.A., Carr J.K., Foley B., Funkhouser R.K., et al. HIV-1 nomenclature proposal. Science 288 5463 (2000) 55-56
4. Plantier J.C., Leoz M., Dickerson J.E., De Oliveira F., Cordonnier F., Lemee V., et al. A new human immunodeficiency virus derived from gorillas. Nat Med 15 8 (2009) 871-872
5. Fonjungo P.N., Mpoudi E.N., Torimiro J.N., Alemnji G.A., Eno L.T., Lyonga E.J., et al. Human immunodeficiency virus type 1 group m protease in Cameroon: genetic diversity and protease inhibitor mutational features. J Clin Microbiol 40 3 (2002) 837-845
6. Koizumi Y., Ndembi N., Miyashita M., Lwembe R., Kageyama S., Mbanya D., et al. Emergence of antiretroviral therapy resistance-associated primary mutations among drug-naive HIV-1-infected individuals in rural western Cameroon. J Acquir Immune Defic Syndr 43 1 (2006) 15-22
7. Konings F.A., Zhong P., Agwara M., Agyingi L., Zekeng L., Achkar J.M., et al. Protease mutations in HIV-1 non-B strains infecting drug-naive villagers in Cameroon. AIDS Res Hum Retroviruses 20 1 (2004) 105-109
8. Luk K.C., Kaptue L., Zekeng L., Soriano V., Gurtler L., Devare S.G., et al. Naturally occurring sequence polymorphisms within HIV type 1 group O protease. AIDS Res Hum Retroviruses 17 16 (2001) 1555-1561
9. Ndembi N., Abraha A., Pilch H., Ichimura H., Mbanya D., Kaptue L., et al. Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B. J Clin Microbiol 46 1 (2008) 177-184
10. Ndembi N., Takehisa J., Zekeng L., Kobayashi E., Ngansop C., Songok E.M., et al. Genetic diversity of HIV type 1 in rural eastern Cameroon. J Acquir Immune Defic Syndr 37 5 (2004) 1641-1650
11. Ndongmo C.B., Pieniazek D., Holberg-Petersen M., Holm-Hansen C., Zekeng L., Jeansson S.L., et al. HIV genetic diversity in Cameroon: possible public health importance. AIDS Res Hum Retroviruses 22 8 (2006) 812-816
12. Peeters M., Toure-Kane C., and Nkengasong J.N. Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials. Aids 17 18 (2003) 2547-2560
13. Vergne L., Bourgeois A., Mpoudi-Ngole E., Mougnutou R., Mbuagbaw J., Liegeois F., et al. Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage. Virology 310 2 (2003) 254-266
14. Santos A.F., Sousa T.M., Soares E.A., Sanabani S., Martinez A.M., Sprinz E., et al. Characterization of a new circulating recombinant form comprising HIV-1 subtypes C and B in southern Brazil. Aids 20 16 (2006) 2011-2019
15. Stuyver L., Wyseur A., Rombout A., Louwagie J., Scarcez T., Verhofstede C., et al. Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene. Antimicrob Agents Chemother 41 2 (1997) 284-291
16. Santos A.F., Lengruber R.B., Soares E.A., Jere A., Sprinz E., Martinez A.M., et al. Conservation patterns of HIV-1 RT connection and RNase H domains: identification of new mutations in NRTI-treated patients. PLoS ONE 3 3 (2008) e1781
17. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Sympos Ser 41 (1999) 95-98
18. Tamura K., Dudley J., Nei M., and Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24 8 (2007) 1596-1599
19. Salminen M.O., Carr J.K., Burke D.S., and McCutchan F.E. Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses 11 11 (1995) 1423-1425
20. Rhee S.Y., Gonzales M.J., Kantor R., Betts B.J., Ravela J., and Shafer R.W. Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res 31 1 (2003) 298-303
21. Johnson V.A., Brun-Vezinet F., Clotet B., Gunthard H.F., Kuritzkes D.R., Pillay D., et al. Update of the drug resistance mutations in HIV-1. Top HIV Med 16 5 (2008) 138-145
22. Shafer R.W., Rhee S.Y., and Bennett D.E. Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies. Antivir Ther 13 Suppl 2 (2008) 59-68
23. Brehm J.H., Koontz D., Meteer J.D., Pathak V., Sluis-Cremer N., and Mellors J.W. Selection of mutations in the connection and RNase H domains of human immunodeficiency virus type 1 reverse transcriptase that increase resistance to 3′-azido-3′-dideoxythymidine. J Virol 81 15 (2007) 7852-7859
24. Delviks-Frankenberry K.A., Nikolenko G.N., Barr R., and Pathak V.K. Mutations in human immunodeficiency virus type 1 RNase H primer grip enhance 3′-azido-3′-deoxythymidine resistance. J Virol 81 13 (2007) 6837-6845
25. Roquebert B., Wirden M., Simon A., Deval J., Katlama C., Calvez V., et al. Relationship between mutations in HIV-1 RNase H domain and nucleoside reverse transcriptase inhibitors resistance mutations in naive and pre-treated HIV infected patients. J Med Virol 79 3 (2007) 207-211
26. Nkengasong J.N., Janssens W., Heyndrickx L., Fransen K., Ndumbe P.M., Motte J., et al. Genotypic subtypes of HIV-1 in Cameroon. Aids 8 10 (1994) 1405-1412
27. Takehisa J., Zekeng L., Ido E., Mboudjeka I., Moriyama H., Miura T., et al. Various types of HIV mixed infections in Cameroon. Virology 245 1 (1998) 1-10
28. Mamadou S., Vidal N., Montavon C., Ben A., Djibo A., Rabiou S., et al. Emergence of complex and diverse CRF02-AG/CRF06-cpx recombinant HIV type 1 strains in Niger, West Africa. AIDS Res Hum Retroviruses 19 1 (2003) 77-82
29. Powell R.L., Zhao J., Konings F.A., Tang S., Nanfack A., Burda S., et al. Identification of a novel circulating recombinant form (CRF) 36_cpx in Cameroon that combines two CRFs (01_AE and 02_AG) with ancestral lineages of subtypes A and G. AIDS Res Hum Retroviruses 23 8 (2007) 1008-1019
30. Yamaguchi J., Badreddine S., Swanson P., Bodelle P., Devare S.G., and Brennan C.A. Identification of new CRF43_02G and CRF25_cpx in Saudi Arabia based on full genome sequence analysis of six HIV type 1 isolates. AIDS Res Hum Retroviruses 24 10 (2008) 1327-1335
31. Aghokeng A.F., Vergne L., Mpoudi-Ngole E., Mbangue M., Deoudje N., Mokondji E., et al. Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries. Antivir Ther 14 3 (2009) 401-411
32. Vergne L., Diagbouga S., Kouanfack C., Aghokeng A., Butel C., Laurent C., et al. HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon. Antivir Ther 11 5 (2006) 575-579
33. Brehm J.H., Mellors J.W., and Sluis-Cremer N. Mechanism by which a glutamine to leucine substitution at residue 509 in the ribonuclease H domain of HIV-1 reverse transcriptase confers zidovudine resistance. Biochemistry 47 52 (2008) 14020-14027
34. Nikolenko G.N., Palmer S., Maldarelli F., Mellors J.W., Coffin J.M., and Pathak V.K. Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: balance between RNase H activity and nucleotide excision. Proc Natl Acad Sci U S A 102 6 (2005) 2093-2098